| Lipids Management |
1 |
1 |
| Cardiovascular Risk Management |
0 |
1 |
| LDL Cholesterol |
0 |
0.5 |
| Coronary Artery Disease (CAD) |
0 |
0.45 |
| Heart |
0 |
0.45 |
| Lipoproteins |
0 |
0.45 |
| Statins |
0 |
0.45 |
| Triglycerides |
0 |
0.36 |
| Type 2 Diabetes Mellitus |
0 |
0.29 |
| Apolipoproteins |
0 |
0.27 |
| Hypertriglyceridemia |
0 |
0.27 |
| Thromboembolism |
0 |
0.17 |
| PPAR Agonists |
0 |
0.15 |
| Cerebrovascular Accident |
0 |
0.12 |
| Dyslipidemia |
0 |
0.09 |
| Europe |
0 |
0.09 |
| Infarction |
0 |
0.09 |
| Insulin Resistance |
0 |
0.09 |
| Ischemic Stroke |
0 |
0.09 |
| Receptors |
0 |
0.09 |
| Myocardial Infarction (MI) |
0 |
0.07 |